Chronic myeloid neoplasms including myelodysplastic neoplasms (MDS) and
myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell (HSC) disorders …

Chronic myeloid neoplasms, including myelodysplastic syndrome (MDS), myeloproliferative
neoplasms (MPN), and MDS/MPN, are clonal disorders of hematopoietic stem cells. They …

During the process of hematopoiesis, hematopoietic stem cells (HSCs) undergo hierarchical
differentiation and maturation to develop into mature effector cells through a tightly regulated …

In hematologic neoplasms, the identification of recurrent disease-associated phenotypic
features in general is followed after a prolonged period by the identification of disease …

Abstract The World Health Organization classification (WHO-HAEM5) and the International
Consensus Classification (ICC 2022) of myeloid neoplasms are based on the integration of …

Standardization of the detection and quantification of leukocyte differentiation markers by the
EuroFlow Consortium has led to a major step forward in the integration of flow cytometry into …

This fourth edition presents an updated and expanded text and illustrations to reflect
continued morphologic, immunophenotypic, and especially molecular advances in the field …

Myelodysplastic neoplasms (MDS) are clonal hematopoietic neoplasms defined by
cytopenias and morphologic dysplasia. This definition distinguishes MDS from clonal …

Myelodysplastic syndromes (MDSs) are a heterogeneous group of hematopoietic stem cell
diseases categorized by dysplasia in one or more hematopoietic cell lineages, as well as …

Background Flow cytometry immunophenotyping (FCIP) can improve diagnosis of
myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms …